ETrade Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,352
Closed -$255K 881
2020
Q1
$255K Sell
2,352
-1,077
-31% -$155K 0.01% 634
2019
Q4
$498K Buy
3,429
+593
+21% +$85.6K 0.01% 556
2019
Q3
$409K Buy
+2,836
New +$414K 0.01% 598
2018
Q4
Sell
-6,381
Closed -$952K 776
2018
Q3
$952K Sell
6,381
-449
-7% -$68.3K 0.03% 380
2018
Q2
$1.05M Buy
6,830
+1,974
+41% +$298K 0.03% 340
2018
Q1
$675K Buy
4,856
+2,627
+118% +$386K 0.02% 434
2017
Q4
$306K Buy
+2,229
New +$295K 0.01% 623
2013
Q4
Sell
-105
Closed -$9K 881
2013
Q3
$9K Hold
105
﹤0.01% 736
2013
Q2
$9K Buy
+105
New +$8.72K ﹤0.01% 671

Other funds holding LH

ETrade Capital Management's LH Position: Q2 2020 in Review

ETrade Capital Management sold out of Labcorp (LH) in Q2 2020, closing a stake of 2,352 shares — an estimated $255K sold.

ETrade Capital Management first reported a position in LH in Q2 2013 and held it in 9 quarters. The position peaked at $1.05M in Q2 2018. 799 funds tracked by Wall St. Rank hold LH as of Q2 2020.

  • ETrade Capital Management reported no remaining Labcorp position as of Q2 2020 after selling out during the quarter.
  • ETrade Capital Management sold 2,352 Labcorp shares in Q2 2020, an estimated $255K.
  • ETrade Capital Management first reported a position in Labcorp in Q2 2013 and held it in 9 quarters.
  • ETrade Capital Management's Labcorp position peaked at $1.05M in Q2 2018.
  • 799 funds tracked by Wall St. Rank held Labcorp as of Q2 2020.

Based on ETrade Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.